Summary.-Two naturally occurring cytotoxic cell populations have been identified in the peritoneal cavity of mice inoculated with C. parvum (CP), and are distinguishable on the basis of target-cell reactivity and intrinsic properties. The first effector cell was non-adherent to nylon wool and glass and non-phagocytic. These cells were selectively cytotoxic to the NK-sensitive target cell line K562, and present in the peritoneal cavity of mice 2 days after treatment with 700 jig of CP. The second cytotoxic effector cell was adherent to nylon wool and glass, and killed EL4 lymphoma cells derived from in vivo tumour transplants; these target cells are susceptible to phagocytic cell killing, but not NK-cell cytotoxicity in short-term (4h) assays. The adherent cytotoxic population of effector cells was present 4 days after inoculation of CP.
Summary.-Two naturally occurring cytotoxic cell populations have been identified in the peritoneal cavity of mice inoculated with C. parvum (CP), and are distinguishable on the basis of target-cell reactivity and intrinsic properties. The first effector cell was non-adherent to nylon wool and glass and non-phagocytic. These cells were selectively cytotoxic to the NK-sensitive target cell line K562, and present in the peritoneal cavity of mice 2 days after treatment with 700 jig of CP. The second cytotoxic effector cell was adherent to nylon wool and glass, and killed EL4 lymphoma cells derived from in vivo tumour transplants; these target cells are susceptible to phagocytic cell killing, but not NK-cell cytotoxicity in short-term (4h) assays. The adherent cytotoxic population of effector cells was present 4 days after inoculation of CP.
In vivo studies showed that CP injected i.p. induced resistance to i.p. challenge with lymphoma EL4 cells, but no resistance was evident when the challenge dose was administered s.c. Adoptive-transfer studies showed that the effector cell type responsible for inhibiting tumour growth was nylon-wool adherent, probably CPactivated macrophages.
IMMUNOSTIMULANTS such as Bacillus
Calmette Guerin (BCG) and Corynebacteriurn parvum (CP) have been found to enhance non-specific anti-tumour cytotoxicity, and in particular NK cells (Wolfe et al., 1976; Henney et al., 1978; Ojo, 1979; Gidlund et al., 1978; Oehler et al., 1978) .
Experimental evidence from these studies supports the concept of indirect stimulation of cytotoxic cells via interferon induction, which itself effectively stimulates rodent (Senik et al., 1979; Djeu et al., 1979a,b) and human (Trinchieri & Santoli, 1978; Einhorn et al., 1978; Moore & Potter, 1980) natural killer (NK) cells, and in vivo its production is under genetic control (Kiessling & Wigzell, 1979) . Immunostimulants such as BCG and CP have also been shown to be effective in promoting macrophage activity (Milas & Scott, 1978; Baldwin & Pimm, 1978) and to enhance resistance to tumour transplantation (Henney et al., 1978; Ojo, 1979) . Potentiation of the non-specific cytotoxicity by CP has recently been shown to be dependent on the dose and strain of the organism (Flexman & Shellam, 1980) . In the present study, CP treatment of mice was shown to activate two populations of cytotoxic effector cells, distinguishable by their reactivity to targets of known susceptibility to cytolysis by NK or adherent phagocytic cells. In addition, experiments were performed to investigate the relevance of both cell types in controling the in vivo growth of a transplantable murine lymphoma. Beside NK cells and macrophages, there appears to be an effector cell which may be related to NK cells, but differs from NK in several basic properties, and has been termed the natural cytotoxic (NC) cell Paige et al., 1978 Nylon-wool column fractionation.-This method is described elsewhere (Julius et al., 1973; Rees et al., 1975 Carbonyl iron treatment.-Four mg of carbonyl iron was added to 107 effector cells in 1 ml of M199, and the mixture incubated at 37°C for 30 min. Carbonyl iron was sedimented on a magnet for 10 min at 40C, the supernatant removed and the sedimentation repeated. The recovered cells were washed and adjusted to 5 x 107/ml in M199 and used in experiments.
Preparation and use of anti-Thy 1:2 antiserum.-Anti-Thy 1: 2 serum was prepared by immunization of AKR mice with 3 weekly injections of 107 CBA thymocytes. The antiserum was collected one week after the 3rd immunization, and was shown to demonstrate selective complement dependent cytotoxicity for thymocytes from CBA and C57BL mice, but not AKR mice. This serum has also been shown to specifically abolish antitumour T-cell reactivity towards C57BL murine sarcomas (Kadhim & Rees, unpublished cell sensitivity to treatment with anti-Thy 1: 2 + complement, and carbonyl iron; these results are shown in Table II . Thus, cells harvested 2 days after PEC stimulation and reactive to K562 targets, were not affected by anti-Thy 1:2 + complement treatment, or carbonyl iron treatment. In contrast, cytotoxicity to both K562 and EL4 targets mediated by stimulated PEC harvested 4 days after (CP) inoculation, was removed by carbonyl-iron treatment but was unaffected by treatment with anti-Thy 1: 2 + complement (Table II) . These results suggest that the effector cells present 2 days after CP stimulation, and mediating cytotoxicity to K562 are most probably NK cells, whereas the cells reactive to EL4 targets display the properties of macrophages.
To eliminate the possible involvement of polymorphonuclear leucocytes in cytotoxicity to K562 and EL4 targets, effector cells from 2 and 4 day CP-stimulated mouse PEC were fractionated on FicollTriosil to yield an interface fraction mainly of mononuclear cells, and a pellet containing 65-75oo polymorphonuclear leucocytes. When these cell fractions were assayed for cytotoxicity, the observed killing of both targets resided in the interface fraction; the polymorphonuclear leucocyte-enriched fraction failed to show any significant cytotoxicity (Table III) .
Enrichment of cytotoxicity was found (Table IV) . mice. The incidence of tumours in these animals is shown in Table V . Control mice injected s.c. with 103 EL4 lymphoma cells alone developed progressive lymphomas, whereas injection of PEC harvested 4 days after CP, in admixture with EL4 cells, caused a significant reduction in lymphoma incidence at E: T ratios of 1000: 1, 100: 1 and 10:1 (Table V) . In contrast, PEC harvested 2 days after CP failed to inhibit EL4 lymphoma cells growth, and transfer of PEC harvested 7 days after CP was only effective in reducing the tumour incidence and size (P<0-01) at a 1000:1 ratio. The finding that adoptive transfer of only PEC harvested 4 days after CP inoculation prevented the development of EL4 lymphomas in vivo agrees with the results from the cytotoxicity tests. PEC from normal C57BL mice failed to influence the growth of EL4 cells in adoptivetransfer experiments (results not shown).
To determine further which cell fraction was effective in preventing EL4 lymphoma growth, PEC were harvested from mice 4 days after inoculation with 700 ,ug of CP and the cells fractionated into nylonwool-eluted and nylon-wool-retained populations. These fractions were separately mixed with 103 lymphoma EL4 tumour cells at E: T ratios of I: 1, 10: 1, 100: 1 and 1000: 1, and the mixtures inoculated s.c.
into groups of mice. The incidence of tumours in these animals is shown in Table VI . The nylon-wool-eluted fraction of PEC showed no capacity to limit tumour growth; in contrast significant inhibition of tumour growth was found for column-retained cells at E: T ratios of 1000: 1, 100: 1 and 10: 1. In addition, there was a significant delay in tumour appearance for mice inoculated with CP-stimulated nylon-wool-retained PEC transferred at 10: 1 and 1: 1 ratios (P < 0-001 and P < 0 05 respectively).
DISCUSSION
The past decade has witnessed numerous attempts to suppress tumour growth by administering immune stimulants. Notable successes have been achieved, particularly following the intralesional injection of Bacillus Calmette Guerin (BCG), which has caued the regression of large tumours in experimental animals (Zbar et al., 1972; Baldwin & Pimm, 1973) . Similarly, CP has also been shown to possess anti-tumour effects (Castro, 1974; Ojo, 1979; Milas & Scott, 1978 Ojo (1979) has shown that CP administered i.p. induced systemic resistance to transplantation of the YAC lymphoma line. This tumour is NK-cell sensitive (Kiessling et al., 1975; Herberman et al., 1975; Ojo, 1979) while in vivo-derived EL4 cells are only weakly susceptible to NK cells (Herberman et al., 1975) ; and the Meth A tumour has been reported to be killed by NC cells but insensitive to NK cells Paige et al., 1978) . These observations suggest that CP enhances systematic NK reactivity, leading to effective in vivo growth inhibition of NK-sensitive targets. The results shown here indicate that local suppression of EL4 cells is not mediated by NK cells, but by cytotoxic macrophages. Oehler et al. (1978) have reported enhanced PEC anti-tumour cytotoxicity in rats given i.p. CP, which was maintained for up to 5 weeks; however, the cytotoxicity was not fully characterized as being NK-cell or macrophage mediated. In the present study we have examined the induction/augmentation of cytotoxicity in vivo by CP, and shown that two distinct populations of cytotoxic effector cells are stimulated. The first, a non-adherent, non-phagocytic cell type showed selective killing of K562 cells and was present 2 days after in vivo administration of CP. Characterization studies suggest that these effector cells are NK cells. The second was glass adherent and phagocytic, and was present 4 days after CP administration, showing reactivity to EL4 target cells from an in vivo transplant line. The selective reactivity of these effector cells to different target lines suggests the expression of target receptor sites specific for different effector-cell populations.
Although the in vivo role of natural killer, and other naturally cytotoxic effector cell mechanisms, is not yet clear, there is evidence that NK cells may be of prime importance in immune surveillance against cancer cells (Kiessling & Wigzell, 1979) and may demonstrate in vivo cytotoxicity to blood-borne metastases (Hanna & Fidler, 1980) . The results shown here would also suggest that tumour cells possessing an innate resistance to NKmediated cytotoxicity may prove sensitive to phagocytic cells, which may constitute an important natural anti-tumour effector mechanism.
